Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subacute cutaneous lupus erythematosus

K M David-Bajar1

  • 1Department of Medicine, Fitzsimons Army Medical Center, Aurora, Colorado 80045-5001.

The Journal of Investigative Dermatology
|January 1, 1993
PubMed
Summary

Subacute cutaneous lupus erythematosus (SCLE) is a distinct subset of lupus characterized by sun-sensitive skin disease and often musculoskeletal complaints. SCLE patients frequently have anti-Ro antibodies and specific HLA types, with ongoing research into its unique immunofluorescence patterns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Waldenström macroglobulinemia-induced bullous dermatosis.

Archives of dermatology·1998
Same author

Pathology, immunopathology, and immunohistochemistry in cutaneous lupus erythematosus.

Lupus·1997
Same author

In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease.

The Journal of investigative dermatology·1995
Same author

Microscopic polyarteritis. Report of a case with cutaneous involvement and antimyeloperoxidase antibodies.

Archives of dermatology·1992
Same author

Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.

The Journal of investigative dermatology·1992

Area of Science:

  • Dermatology
  • Immunology
  • Rheumatology

Background:

  • Subacute cutaneous lupus erythematosus (SCLE) is recognized as a distinct subset of lupus erythematosus.
  • SCLE patients typically present with prominent photoaggravated skin disease and musculoskeletal complaints, but generally lack significant systemic involvement.
  • Distinctive features of SCLE include frequent anti-Ro antibodies and enrichment for human histocompatibility antigens (HLA) B8 and DR3.

Purpose of the Study:

  • To review and synthesize published observations on subacute cutaneous lupus erythematosus (SCLE) over 13 years.
  • To highlight key clinical, serological, and genetic features of SCLE.
  • To discuss areas of controversy and recent findings in SCLE research.

Main Methods:

  • Literature review of published reports on SCLE patients following the initial Sontheimer study.

Related Experiment Videos

  • Analysis of clinical observations, serological findings (anti-Ro antibodies), and genetic associations (HLA types).
  • Discussion of histopathological findings and immunofluorescence patterns.

    • Main Results:

    • SCLE is associated with photoaggravated skin disease and musculoskeletal symptoms.
    • SCLE patients frequently exhibit anti-Ro antibodies and specific HLA types (B8, DR3).
    • SCLE can be associated with other rheumatic diseases, and photoactive medications may induce SCLE lesions.

    Conclusions:

    • SCLE represents a unique subset of lupus erythematosus with characteristic clinical and serological features.
    • Ongoing research is exploring histopathological differences from discoid lupus erythematosus (DLE) and the significance of immunoglobulin G (IgG) deposition patterns in SCLE.
    • The unique immunofluorescence pattern may indicate in vivo binding of anti-Ro antibodies to keratinocytes.